ketamine has been researched along with Causalgia in 4 studies
Ketamine: A cyclohexanone derivative used for induction of anesthesia. Its mechanism of action is not well understood, but ketamine can block NMDA receptors (RECEPTORS, N-METHYL-D-ASPARTATE) and may interact with sigma receptors.
ketamine : A member of the class of cyclohexanones in which one of the hydrogens at position 2 is substituted by a 2-chlorophenyl group, while the other is substituted by a methylamino group.
Causalgia: A complex regional pain syndrome characterized by burning pain and marked sensitivity to touch (HYPERESTHESIA) in the distribution of an injured peripheral nerve. Autonomic dysfunction in the form of sudomotor (i.e., sympathetic innervation to sweat glands), vasomotor, and trophic skin changes may also occur. (Adams et al., Principles of Neurology, 6th ed, p1359)
| Excerpt | Relevance | Reference |
|---|---|---|
| "Evidence suggests that complex regional pain syndrome (CRPS) is a manifestation of microvascular dysfunction." | 5.43 | A Novel Compound Analgesic Cream (Ketamine, Pentoxifylline, Clonidine, DMSO) for Complex Regional Pain Syndrome Patients. ( Russo, MA; Santarelli, DM, 2016) |
| "His pain was diagnosed as neuropathic pain (complex regional pain syndrome, type II)." | 5.30 | The NMDA-receptor antagonist ketamine abolishes neuropathic pain after epidural administration in a clinical case. ( Miyazaki, M; Morita, S; Nanbu, T; Takahashi, H; Yanagida, H, 1998) |
| "Evidence suggests that complex regional pain syndrome (CRPS) is a manifestation of microvascular dysfunction." | 1.43 | A Novel Compound Analgesic Cream (Ketamine, Pentoxifylline, Clonidine, DMSO) for Complex Regional Pain Syndrome Patients. ( Russo, MA; Santarelli, DM, 2016) |
| "His pain was diagnosed as neuropathic pain (complex regional pain syndrome, type II)." | 1.30 | The NMDA-receptor antagonist ketamine abolishes neuropathic pain after epidural administration in a clinical case. ( Miyazaki, M; Morita, S; Nanbu, T; Takahashi, H; Yanagida, H, 1998) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (25.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 3 (75.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Perić, P | 1 |
| Russo, MA | 1 |
| Santarelli, DM | 1 |
| Sakamoto, E | 1 |
| Shiiba, S | 1 |
| Noma, N | 1 |
| Okada-Ogawa, A | 1 |
| Shinozaki, T | 1 |
| Kobayashi, A | 1 |
| Kamo, H | 1 |
| Koike, K | 1 |
| Imamura, Y | 1 |
| Takahashi, H | 1 |
| Miyazaki, M | 1 |
| Nanbu, T | 1 |
| Yanagida, H | 1 |
| Morita, S | 1 |
4 other studies available for ketamine and Causalgia
| Article | Year |
|---|---|
[Complex regional pain syndrome--pathophysiology, clinical presentation and treatment].
Topics: Analgesics; Causalgia; Glucocorticoids; Humans; Ketamine; Reflex Sympathetic Dystrophy | 2013 |
A Novel Compound Analgesic Cream (Ketamine, Pentoxifylline, Clonidine, DMSO) for Complex Regional Pain Syndrome Patients.
Topics: Adrenergic alpha-Agonists; Adult; Analgesics; Anesthetics, Dissociative; Anti-Infective Agents, Loca | 2016 |
A possible case of complex regional pain syndrome in the orofacial region.
Topics: Aged; Anesthetics, Dissociative; Causalgia; Facial Pain; GABA Modulators; Humans; Injections, Intrav | 2010 |
The NMDA-receptor antagonist ketamine abolishes neuropathic pain after epidural administration in a clinical case.
Topics: Adolescent; Causalgia; Humans; Injections, Epidural; Ketamine; Leg; Male; Pain; Receptors, N-Methyl- | 1998 |